МANOMETRY IN THE MANAGEMENT OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE
Article Sidebar
Main Article Content
Аннотация:
Gastroesophageal reflux disease (GERD) is a widespread disease that has a significant impact on the quality of life of patients and is a leading risk factor for the development of esophageal adenocarcinoma. Currently, proton pump inhibitor therapy (PPI) is the basic treatment for patients with GERD, but 1/3 of patients show resistance to the prescribed therapy.
Article Details
Как цитировать:
Библиографические ссылки:
Abu Ali ibn Sina (Avicenna). Canon of Medicine. Ed. ENIO; 2003.
Rossetti M. The reflux disease of the esophagus--clinical-surgicalaspects. Hippokrates. 1967;38(3):92-97.
Dent J, Brun J, Fendrick M, Fennerty J, Janssens P, Kahrilas K, Lauritsen J, Reynolds M, Shaw N. Talley on behalf of the Genval Workshop Group An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999;44(suppl2):S1-S16.
doi:10.1136/gut.44.2008.S1
Vakil N, Zanten S, Kahrilas P, Dent J, Jones R. Global Consensus Group The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gas-troenterol.2006;101(8):1900-1920.
doi: 10.1111/j.1442-2050.2011.01271.x
Ivashkin V.T., Maev I.V., Trukhmanov A.S., Baranskaya E.K., Dronova O.B., Zairatyants O.V., Pasechnikov V.D., Saifutdinov R.G., Sheptulin A.A., Kucheryavy Yu.A., Lapina T.L., Storonova O.A., Kaibysheva V.O. Gastroesophageal reflux disease. Clinical guidelines. Moscow, 2014.
Ivashkin V.T., Maev I.V., Trukhmanov A.S. Barret's esophagus. In two volumes. M.: Publishing house "Shiko"; 2011.
Dent J. Endoscopic grading of reflux oesophagitis: the past, present and future. Best Pract Res Clin Gastroenterol. 2008;22(4):585-599.
doi:10.1016/j.bpg.2008.01.002
6th United Europeangastroenterology week. Birmingham, United Kingdom, 18-23 October 1997. Abstracts. gut. 1997;41(Suppl 3):A1-258,E1-61.
El-Serag H, Sweet S, Winchester C, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.gut2014;63:871-880.
doi:10.1136/gutjnl-2012-304269
10. Khodjieva GS Pharmacoeconomics and the patients' compliance as an essential part of successful therapy of iron deficiency anemia. //Indonesian Journal of Innovation Studies-Vol. 18 (2022): April 2022–2-7p.
11.Khodjiyeva GS Pharmacoeconomics and the patients compliance as an essential part of therapy of iron deficiency anemia // Uzbek medical journal. - 2020. - Volume 6, Issue 1. - P. 37-43.
12. Khodjiyeva GS Pharmacoeconomics and the patients compliance as an essential part of successful therapy of iron deficiency anemia // Evropean journal of molecular and clinical medicine. - 2020. - Volume 7, Issue 11. - P. 2550-2554